Physician profile
Raja Sharma
NPI 1447269568
$18,014.59
in general payments reported to CMS, 2019-2025
55 companies · $2,470 in 2025
The $2,470 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,150 · 2020: $3,317 · 2021: $2,140 · 2022: $2,142 · 2023: $1,878 · 2024: $1,917 · 2025: $2,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,721 · Travel and Lodging: $544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,721.25 |
| Travel and Lodging | $544.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,959.15 | 2019-2025 | Cardiomems, Gallant |
| Janssen Pharmaceuticals, INC | $1,572.95 | 2019-2024 | Xarelto, Opsumit, Uptravi |
| Boston Scientific Corporation | $1,361.19 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Ekosonic |
| E.R. Squibb & Sons, L.L.C. | $1,279.61 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $1,177.53 | 2019-2025 | |
| Medtronic, INC. | $1,000.58 | 2021-2025 | Venaseal, Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $802.96 | 2019-2025 | Jardiance |
| Amgen INC. | $465.70 | 2019-2025 | Repatha, Repatha |
| Amarin Pharma, INC. | $453.49 | 2019-2023 | |
| Bard Peripheral Vascular, INC. | $430.18 | 2021-2024 | Rotarexs 6 F X 135 Cm |
| Pfizer INC. | $345.56 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $319.91 | 2019-2025 | Farxiga, Wainua |
| Esperion Therapeutics, INC. | $316.22 | 2020-2025 | Nexletol |
| Medtronic Vascular, INC. | $312.32 | 2019 | |
| Abiomed | $280.91 | 2022-2025 | Impella |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $269.27 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $220.38 | 2021-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $200.30 | 2019-2023 | |
| Heartflow, INC. | $193.93 | 2024-2025 | |
| Shockwave Medical, INC | $192.11 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Alnylam Pharmaceuticals INC. | $154.51 | 2022-2025 | Onpattro |
| Siemens Medical Solutions USA, INC. | $146.97 | 2021 | |
| Azurity Pharmaceuticals, INC. | $128.43 | 2023-2025 | Edarbi, Edarbi |
| Bridgebio Pharma, INC. | $123.55 | 2025 | Attruby |
| Regeneron Healthcare Solutions, INC. | $121.58 | 2019-2024 | Praluent, Evkeeza |
| Ge Healthcare | $107.65 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $93.10 | 2023-2024 | Inpefa |
| Cardiovascular Systems INC. | $82.39 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $61.58 | 2023 | Optimizer |
| Cardinal Health 200 LLC | $61.13 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $58.30 | 2019-2025 | Lifevest |
| Inspire Medical Systems, INC. | $57.74 | 2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $55.74 | 2021-2025 | |
| Angiodynamics, INC. | $55.69 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $49.58 | 2023-2024 | Opsumit, Uptravi |
| Cordis US Corp. | $39.66 | 2022-2025 | Mynx Control Venous |
| Intuitive Surgical, INC. | $37.26 | 2024 | |
| Philips North America LLC | $36.79 | 2025 | Igt Devices Systems Undivided |
| Kestra Medical Technology Services, INC. | $33.60 | 2025 | Assure Wcd |
| Glaxosmithkline, LLC. | $32.06 | 2025 | Arexvy, Shingrix |
| Thrombolex, INC. | $29.39 | 2025 | Bashir Endovascular Catheter |
| Cvrx, INC. | $28.58 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $26.62 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $26.14 | 2019-2021 | |
| Inari Medical, INC. | $24.89 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lilly USA, LLC | $24.59 | 2025 | Mounjaro, Zepbound |
| Edwards Lifesciences Corporation | $24.58 | 2020 | |
| Getinge USA Sales, LLC | $23.66 | 2021 | |
| Biotronik INC. | $21.15 | 2023 | Biomonitor |
| Recor Medical INC | $21.00 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bsn Medical INC | $17.81 | 2019 | |
| Astellas Pharma US INC | $15.94 | 2019 | |
| Scpharmaceuticals INC. | $13.19 | 2024 | |
| Kiniksa Pharmaceuticals, LTD. | $12.93 | 2021 | |
| Infobionic, INC | $12.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raja Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.